Table 2.
cHL subgroup | EBV+ | EBV− | P value (EBV+ vs. EBV−) | |||
---|---|---|---|---|---|---|
N | KIR B Carriers (%) | N | KIR B Carriers (%) | |||
Subtype | ||||||
NS | 49 | 24 (49%) | 82 | 65 (79%) | 0.0003 | |
Non-NS | 36 | 29 (81%) | 12 | 7 (58%) | ns | |
Sex | ||||||
male | 65 | 44 (68%) | 45 | 35 (76%) | ns | |
female | 20 | 9 (45%) | 48 | 37 (77%) | 0.01 | |
Age | ||||||
Age<45 | 61 | 39 (64%) | 73 | 59 (81%) | 0.03 | |
Age>=45 | 24 | 14 (58%) | 21 | 13 (62%) | ns |
NS, nodular sclerosis; ns, not significant.